Ovarian Cancer Market Research Reports

Your Ovarian Cancer Market Guide with research reports, industry analysis, market forecasts, market share, size, etc.
RSS Sort By :
TITLE Price Buy Now More options

Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, ''Metastatic Ovarian Cancer - Pipeline Review, H2 2013'', provides an overview of the indication’s therapeutic pipeline. This report provid...

$ 2000


Global Markets Direct’s, ''Ovarian Cancer Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Cancer, co...

$ 2500


Epithelial Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, ''Epithelial Ovarian Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provid...

$ 2000


Ovarian Cancer Global Clinical Trials Review, H2, 2012 Summary GlobalData''s clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H2, 2012" provides data on the Ovarian Cancer clinical trial scenario. This re...

$ 2500


Metastatic Ovarian Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Metastatic Ovarian Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provid...

$ 2000


Ovarian Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Ovarian Cancer - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the ...

$ 2500


Report SummaryClinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in OncologyGBI Research, the leading business intelligence pro...

$ 3500


Avastin (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, “Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Avastin sales forecasts for US, EU5 and Japan. In add...

$ 2000


Gemzar (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, “Gemzar (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Gemzar sales forecasts for US, EU5 and Japan. In additi...

$ 2000


Farletuzumab (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, “Farletuzumab (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Farletuzumab sales forecasts for US, EU5 an...

$ 2000


Votrient (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, “Votrient (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Votrient sales forecasts for US, EU5 and Japan. In ...

$ 2000


Hycamtin (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, “Hycamtin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Hycamtin sales forecasts for US, EU5 and Japan. In ...

$ 2000


Opaxio (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, “Opaxio (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Opaxio sales forecasts for the US. In addition, it cove...

$ 2000


GlobalData’s pharmaceuticals report, “Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Doxil/Caelyx sales estimates for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug...

$ 2000


Vargatef (Ovarian Cancer) – Analysis and Forecats to 2020SummaryGlobalData’s pharmaceuticals report, “Vargatef (Ovarian Cancer) - Analysis and Forecats to 2020” provides Vargatef sales forecasts for the US and EU5. In addit...

$ 2000


Karenitecin (Ovarian Cancer) – Analysis and Forecast to 2020SummaryGlobalData’s pharmaceuticals report, "Karenitecin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Karenitecin sales estimates for the US, EU and...

$ 2000


Paclical (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, "Paclical (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Paclical sales estimates for the US and EU5. In add...

$ 2000


GlobalData’s pharmaceuticals report, "Paclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Paclitaxel sales forecasts for the US, EU and Japan. In addition, it covers detailed clinical assessment of the drug, fac...

$ 2000


Cisplatin (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, "Cisplatin (Ovarian Cancer) - Analysis and Forecasts to 2020” provides Cisplatin sales forecasts for the US, EU and Japa...

$ 2000


AMG 386 (Ovarian Cancer) – Analysis and Forecasts to 2020SummaryGlobalData’s pharmaceuticals report, "AMG 386 (Ovarian Cancer) - Analysis and Forecasts to 2020” provides AMG 386 sales forecasts for the US, EU and Japan. In ...

$ 2000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: